Bayer and Janssen Pharmaceuticals manufactured and marketed Xarelto (RIVAROXABAN), a blood thinning drug, which has been proven to cause an increased risk of bleeding events.

These deadly events include GI bleeds or intracranial hemorrhages. The allegations regarding Xarelto are that the drug is unreasonably dangerous with regular treatment. This lawsuit is very similar to the settled litigation regarding the drug Pradaxa as it has been known to cause patients to bleed to death.

Xarelto is prescribed to reduce the risk of a blood clotting event (such as a stroke) in patients with atrial fibrillation (“A-Fib”) and is prescribed to prevent deep vein thrombosis and pulmonary blood clots following surgery.

There are safer drug therapies available without any of the negative side-effects. Please be informed and inform others of the serious and dangerous results that can come from taking the drug Xarelto.

We are currently accepting cases and helping those who have suffered an injury or death as a result of a bleeding event caused by Xarelto. If you or anyone you know may have a potential case, we urge you to call us at 888-We-Mean-It (888-936-3264).